Beauty salons join fight against HIV: new online program aims to boost PrEP use among black women

NCT ID NCT06638892

Recruiting now Prevention Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an online program called UPDOs Protective Styles to help Black women in the southeastern US learn about and start using PrEP, a medicine that prevents HIV. Researchers will recruit 1000 participants from 32 beauty salons in areas with high HIV rates. One group will use the program, which includes videos, blogs, and telehealth access, while the other group gets standard HIV prevention materials. The study will track how many people start and continue using PrEP over a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (online program with videos, blogs, and telehealth access)
What this could lead to: If it works, this could point toward a community-based way to increase PrEP use and reduce HIV rates among Black women in the southeastern US.
What could go wrong: This is a behavioral study, not a drug trial, so results depend on participation and follow-up. It may not work in other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

posterior leukoencephalopathy syndrome HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREVENTION PREP

Contacts and locations

Locations

Duke University School of Nursing
RECRUITING

Durham, North Carolina, 27710, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.